News | July 13, 2009

ProCure Opens Proton Therapy Center in Oklahoma City

July 13, 2009 - The new ProCure Proton Therapy Center in Oklahoma City celebrated its official grand opening on July 8, 2009, where patients with head and neck, brain, central nervous system, prostate and some pediatric cancers will be treated at the new Center

The center is the first in a network of ProCure centers, which treat patient with proton therapy, to open across the country. ProCure has a second center under construction in the suburbs of Chicago, scheduled to open in early 2011; and centers in development in New Jersey, south Florida and Detroit, Mich.

According to Procure Inc., there is a need for protons that is not accommodated for, as an estimated 250,000 patients could benefit from proton therapy annually while only 6,000 treatment slots are available through the five centers that have been operating to date.

The Procure Proton Therapy Center in Oklahoma City is affiliated with INTEGRIS Health, the largest Oklahoma-owned, not-for-profit health system in the state. INTEGRIS is opening the cancer institute adjacent to the proton therapy Center and will provide treatment and services to patients who may need additional care while undergoing proton therapy.

The 60,000-square-foot center will have four treatment rooms with a treatment capacity of 1,500 patients a year. Patients will be chosen according to medical appropriateness and evaluated by a physician review board. Patients under treatment will have personal care teams of medical professionals who will remain with them throughout their treatment. The team will involve patients’ personal physicians to allow for a continuum of care.

For more information: www.procure.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation